Delivering market success for concept to patient
24 October 2024 | By
Whitepaper - Delivering Market Success for Pharma Partners from Concept to Patient
List view / Grid view
24 October 2024 | By
Whitepaper - Delivering Market Success for Pharma Partners from Concept to Patient
Selecting container closure components with confidence:A data-driven approach to Container Closure Integrity.
This application note explores how to determine the feasibility and the impact of the single temperature for environmental monitoring microorganisms.
Simplify your move from a vial to a prefilled syringe – lifecycle planning for containment and delivery of biologics drug products
How you can cut through complexity, gain speed and get your drug to the patient as soon as possible.
With complex processes and stringent regulatory requirements, the path to developing a combination product can be uncertain and challenging
5 August 2024 | By
Speed to market is a critical aspect of developing new pharmaceutical products, and scale-up – or scale-down – can play a key part in that process.
31 July 2024 | By
This whitepaper looks at benefits of measuring conductivity on-line, and calibration and temperature compensation criteria for USP compliance.
22 July 2024 | By
These longer synthetic pathways present challenges for process chemists hoping to achieve an efficient API manufacturing process.
Peak tracking in liquid chromatography (LC) method development can be challenging due to retention variations and co-elution. LabSolutions MD software with LCMS-2050 SQ-MS simplifies peak identification and automates method and sequence creation, enabling efficient development of reliable separation methods.
Specialised microbial testing is key in drug development to mitigate contamination risks, which threaten drug efficacy and patient safety. Bruker's MALDI Biotyper® at MPL, Austria, ensures accurate and robust testing, in a high-throughput workflow, delivering reproducible results.
Ambili Menon, Pharma Quality Control, bioMérieux Inc. addresses the task of microbiological testing for advanced therapeutic medicinal products.
Endotoxin testing continues to evolve alongside the industry’s need for more sustainable methods that reduce ecological impact. Nicola Reid, Associate Director of Endotoxin Products, Charles River Labs, reflects on these developments which are driven by the 3Rs (replacement, reduction and refinement).
Viral vector manufacturing presents many challenges related to HEK cell line development, fluid transfer and product viability in the cold chain.
This case study looks at how an online microbial analyzer provides real-time bioburden monitoring for rapid response to adverse water system events.